Valuation: Viatris Inc.

Capitalization 1.92TCr 1.65TCr 1.51TCr 1.44TCr 2.64TCr 1,84100Cr 2.68TCr 18TCr 7.01TCr 87TCr 7.2TCr 7.05TCr 3,04500Cr P/E ratio 2026 *
63.4x
P/E ratio 2027 * 31.8x
Enterprise value 3.13TCr 2.69TCr 2.46TCr 2.35TCr 4.3TCr 3,00100Cr 4.38TCr 30TCr 11TCr 1,42500Cr 12TCr 11TCr 4,96300Cr EV / Sales 2026 *
2.12x
EV / Sales 2027 * 2x
Free-Float
92.11%
Yield 2026 *
3.09%
Yield 2027 * 3.17%
1 day-4.52%
1 week-4.02%
Current month+10.31%
1 month+18.90%
3 months+4.50%
6 months+53.73%
Current year+32.37%
1 week 16.4
Extreme 16.4
17.53
1 month 14.06
Extreme 14.06
17.53
Current year 12.19
Extreme 12.19
17.53
1 year 8.19
Extreme 8.19
17.53
3 years 6.85
Extreme 6.85
17.53
5 years 6.85
Extreme 6.85
17.53
10 years 6.85
Extreme 6.85
50.4
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Change 5d. change 1-year change 3-years change Capi.($)
-4.52%-4.02%+87.49%+75.88% 2.01TCr
-0.00%+5.95%+37.04%+131.28% 90TCr
-1.77%+2.44%+51.53%+42.09% 56TCr
-0.18%+4.39%+15.80%+43.52% 37TCr
+0.88%+2.38%+25.60%+13.56% 33TCr
-0.79%+2.16%+34.41%+13.60% 29TCr
-0.10%+2.93%+29.16%+26.15% 28TCr
-1.79%0.00%+48.90%-4.29% 28TCr
+0.91%+3.07%-31.12%-48.50% 21TCr
-2.22%-1.62%+20.10%+39.73% 18TCr
Average -0.96%+1.61%+31.89%+33.30% 34.13TCr
Weighted average by Cap. -0.53%+3.16%+31.34%+50.02%

Financials

2026 *2027 *
Net sales 1.47TCr 1.27TCr 1.16TCr 1.11TCr 2.03TCr 1,41500Cr 2.06TCr 14TCr 5.39TCr 67TCr 5.54TCr 5.42TCr 2,34000Cr 1.5TCr 1.29TCr 1.18TCr 1.13TCr 2.07TCr 1,44300Cr 2.1TCr 14TCr 5.49TCr 68TCr 5.64TCr 5.52TCr 2,38600Cr
Net income 9.63Cr 8.29Cr 7.58Cr 7.23Cr 13Cr 924.22Cr 13Cr 91Cr 35Cr 438.74Cr 36Cr 35Cr 1.53TCr 40Cr 35Cr 32Cr 30Cr 56Cr 3.88TCr 57Cr 381.56Cr 147.65Cr 1.84TCr 151.7Cr 148.45Cr 6.41TCr
Net Debt 1.21TCr 1.04TCr 951.12Cr 907.46Cr 1.66TCr 1,16000Cr 1.69TCr 11TCr 4.42TCr 55TCr 4.54TCr 4.44TCr 1,91800Cr 1.09TCr 936.26Cr 856.03Cr 816.75Cr 1.5TCr 1,04400Cr 1.52TCr 10TCr 3.97TCr 50TCr 4.08TCr 4TCr 1,72600Cr
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.
Employees
30,000
Date Price Change Volume
15/26/15 16.48 $ -4.52% 98,29,326
14/26/14 17.26 $ -0.63% 78,42,218
13/26/13 17.37 $ +1.16% 1,43,17,223
12/26/12 17.17 $ +1.48% 1,22,67,772
11/26/11 16.92 $ -1.46% 1,41,19,499
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
16.48USD
Average target price
17.50USD
Spread / Average Target
+6.19%

Quarterly revenue - Rate of surprise